As 2024 comes to a close, we reflect on an extraordinary year for the iCMLf community - one defined by progress, collaboration, and a shared determination to improve outcomes for people living with CML.

Empowering the CML Community Through Education

Knowledge is a cornerstone of progress, and this year, we continued to build resources that empower healthcare professionals to deliver world-class care, wherever they are.

• Regional Discussion Groups: These interactive webinars brought together physicians and experts from 44 countries, addressing region-specific challenges and strengthening our collective understanding of CML. Watch now.
  
  
• iCMLf Knowledge Centre: With 1,262 program views across 76 countries, this resource continues to ensure clinicians have access to the latest expert-led guidance. Find out more.
  
  
• iCMLf Conversations: This unique platform connected clinicians, researchers, and patient advocates with leading experts. Over 2,000 on-demand views and active participation underscored the value of these collaborative discussions in advancing global expertise. Watch now. 
  
  

Recognising Excellence in CML Care

At the ESH-iCMLf 26th Annual John Goldman Conference, we celebrated remarkable individuals who are shaping the future of CML care:

• Professor Neil P. Shah was honored for his groundbreaking work in understanding TKI resistance.
• Professor Jeff H. Lipton was recognised for his significant advancements in clinical practice.
• Viji Venkatesh was celebrated for her tireless advocacy and impact on patient care in resource-limited settings.

Watch all keynote presentations

Their achievements inspire us all to keep pushing boundaries in research and care.

Advancing Research Together

Through the dedication of researchers, clinicians, and supporters, we continued to drive forward critical research projects that are reshaping the future of CML care.

• Genomics Alliance: This initiative has grown significantly, with genomic data contributed by physicians representing over 1,100 patients across 11 countries. Together, we’re uncovering the genomic insights that will guide new and improved treatment strategies. Find out more.
• Treatment Free Remission Alliance: With data from 23 sites in 17 countries, this project is identifying factors for successful TKI discontinuation, giving more patients the hope of living free from long-term therapy. Find out more.

Unifying Through Community Events

This year, our community came together in powerful ways to support the shared mission of improving CML outcomes.

• Ride for a Cure: Six cyclists from Incyte tackled 710km through the French Alps, raising awareness and vital funds for our programs. Read more.
• John Goldman Fun Run: Over 45 participants laced up their shoes, breaking records and showcasing the unity of our CML community. These events remind us of what we can achieve when we come together for a common cause. Read more.

Looking Ahead

As we move into 2025, there is much to look forward to. Together, we will continue to make an impact with:

• Celebrations marking 25 years of TKIs, a transformative breakthrough in the history of CML treatment.
• A new Knowledge Centre module, addressing emerging challenges in CML care. - Find out more.
• A dedicated pediatric program to better support children with CML and their families.
• A global survey of practice on the treatment of people with hepatitis B and CML
• And much more!
  
  

Thank You for Being Part of This Journey

Every step forward this year was made possible by you - our supporters, partners, and community members. Your dedication fuels our progress and strengthens our resolve to improve the lives of people living with CML worldwide.

As we reflect on 2024 and look ahead, we are filled with gratitude and excitement for what we can accomplish together in the coming year. Here’s to another year of progress, connection, and shared hope.

With heartfelt thanks,

Your iCMLf team